Tag archive for ‘Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE:TEVA)’
Globes On Tuesday, June 17th, 2014

Jonathon Jacobson’s Highfields Capital opens new position in Teva

– Boston-based Highfields Capital has started a large new position in the pharmaceuticals company.  – – US hedge fund Highfields Capital Management LP has started new positions in Teva Pharmaceutical More...

CFO Eyal Desheh, TEVA
Clive Minchom On Wednesday, January 15th, 2014

Teva Acting CEO Eyal Desheh : We Are Committed to Reducing Costs by $2 Billion

– Acting CEO Eyal Desheh: We are committed to reducing costs by $2 billion and moving production from the US to Europe and Asia. – – The share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; More...

Ilan Shavit On Tuesday, December 24th, 2013

Tesaro Reports Positive Phase III Results For Opko Nausea Drug

– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration More...

Shiri Habib-Valdhorn On Thursday, December 12th, 2013

Fitch Downgrades its Debt Rating for Teva

– Fitch Ratings ranks with Moody’s and S&P and downgraded its debt rating for Teva from “A-” to “BBB+.” – Fitch Ratings has broken ranks with Moody’s and More...

Wordpress site Developed by Fixing WordPress Problems